Skip to main content
Clinical Trials/JPRN-UMIN000009771
JPRN-UMIN000009771
Completed
未知

A Prospective Cohort Study on the Prediction of Effectiveness of Sorafenib on the Basis of Angiogenesis-Related Cytokines - The Prediction of Effectiveness of Sorafenib on the Basis of Angiogenesis-Related Cytokines

Okayama University Hospital0 sites90 target enrollmentJanuary 13, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Okayama University Hospital
Enrollment
90
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2013
End Date
January 1, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with histologically confirmed mixed\-type HCC or sarcomatous change 2\) Patients with a history of molecular\-targeted therapy 3\) Patients with active double cancer (Patients who have early\-stage cancer that does not appear to affect their prognosis and can be controlled by treatment may be enrolled in this study.) 4\) Patients with any serious coexisting condition (e.g., ileus, interstitial pneumonia, pulmonary fibrosis, difficult\-to\-control diabetes mellitus, hypertension, cardiac failure, renal failure, hepatic failure, active peptic ulcer, varicose veins in danger of rupture, severe mental disorder or depression) 5\) Patients with ascites and/or pleural effusion unresponsive to treatment 6\) Patients judged by the principal investigator or subinvestigator to be unsuitable for participation for any other reason (to ensure the safe conduct of this study)

Outcomes

Primary Outcomes

Not specified

Similar Trials